Transglutaminase 2 regulates ovarian cancer metastasis by modulating the immune microenvironment.
Saved in:
| Title: | Transglutaminase 2 regulates ovarian cancer metastasis by modulating the immune microenvironment. |
|---|---|
| Authors: | Ibrahim D; Cancer Research Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.; Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON, Canada., Grondin M; Cancer Research Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.; Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON, Canada., Galpin K; Cancer Research Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.; Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON, Canada., Asif S; Cancer Research Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.; Department of Microbiology and Immunology, University of Ottawa, Ottawa, ON, Canada., Thompson E; Cancer Research Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.; Department of Chemistry and Biomolecular Sciences, University of Ottawa, Ottawa, ON, Canada., Nersesian S; Cancer Research Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.; Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON, Canada., Abou-Hamad J; Cancer Research Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.; Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON, Canada., Echaibi M; Cancer Research Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.; Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON, Canada., Rodriguez GM; Cancer Research Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.; Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON, Canada., Navals P; Department of Chemistry and Biomolecular Sciences, University of Ottawa, Ottawa, ON, Canada., Macdonald E; Cancer Research Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.; Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON, Canada., Ryan B; Department of Chemistry and Biomolecular Sciences, University of Ottawa, Ottawa, ON, Canada., Cook DP; Cancer Research Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.; Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON, Canada., Keillor JW; Department of Chemistry and Biomolecular Sciences, University of Ottawa, Ottawa, ON, Canada., Vanderhyden BC; Cancer Research Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.; Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON, Canada. |
| Source: | Frontiers in immunology [Front Immunol] 2025 Jul 24; Vol. 16, pp. 1639853. Date of Electronic Publication: 2025 Jul 24 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-3224 |
|---|---|
| DOI: | 10.3389/fimmu.2025.1639853 |
